Security key
45258H106
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 52,769,253
- Total 13F shares
- 400,796
- Share change
- -14,954
- Total reported value
- $729,846
- Price per share
- $1.82
- Number of holders
- 12
- Value change
- -$97,971
- Number of buys
- 7
- Number of sells
- 9
Report period
Q1 2023
Institutions
12
Top holders
10
IMMX full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
0.2%
|
105,357
|
$241,268 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
76,537
|
$175,000 | — | 31 Dec 2022 | |
| Murchinson Ltd. |
13F
|
Company |
0.13%
|
67,200
|
$153,888 | — | 31 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
42,960
|
$98,378 | — | 31 Dec 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
33,600
|
$76,944 | — | 31 Dec 2022 | |
| Lynwood Capital Management Inc. |
13F
|
Company |
0.05%
|
25,000
|
$58,000 | — | 31 Dec 2022 | |
| Moss Adams Wealth Advisors LLC |
13F
|
Company |
0.04%
|
20,000
|
$45,800 | — | 31 Dec 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
19,151
|
$43,856 | — | 31 Dec 2022 | |
| InterOcean Capital Group, LLC |
13F
|
Company |
0.03%
|
15,900
|
$36,411 | — | 31 Dec 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.03%
|
15,000
|
$36,000 | — | 31 Dec 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
12,597
|
$28,847 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,687
|
$10,733 | — | 31 Dec 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,356
|
$5,000 | — | 31 Dec 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
350
|
$1,000 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
37
|
$85 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
10
|
$22 | — | 31 Dec 2022 | |
| FMR LLC |
13F
|
Company |
0%
|
7
|
$16 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2022 | |
| Sean Senn |
3/4/5
|
Under 10% owner |
—
class O/S missing
|
899,800
|
$4,205,665 | — | 14 Jul 2022 | |
| Vladimir P. Torchilin |
3/4/5
|
Scientific Co-Founder |
—
class O/S missing
|
905,200
|
$4,230,905 | — | 20 Dec 2021 |
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q1 2023
As of 31 Mar 2023,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
400,796 shares.
The largest 10 holders included
VANGUARD GROUP INC, UMB Bank, n.a., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Moss Adams Wealth Advisors LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, InterOcean Capital Group, LLC, Ground Swell Capital, LLC, Tower Research Capital LLC (TRC), and UBS Group AG.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
18
Q1 2023 holders
12
Holder diff
-6
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.